Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia

Published:2024-05 Issue: Volume:140 Page:107482
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ikoma-Colturato Maura R.V.,Severino Alef Rafael,dos Santos Tosi Juliana Fernanda,Bertolucci Camila Marques,Cuoco Yeda Midori Nakamura,de Mattos Ederson Roberto,Colturato Iago,Silva Fernanda Barbieri Rodrigues,de Souza Mair Pedro,Simione Anderson João,Colturato Vergilio Antonio Rensi

Publisher

Elsevier BV

Reference20 articles.

1. 2021 update on measurable residual disease (MRD) in acute myeloid leukemia (AML): A consensus document from the European LeukemiaNet MRD working party;Heuser;Blood,2021

2. Measurable residual disease (MRD) as a surrogate efficacy-response biomarker in AML;Meddi;Int. J. Mol. Sci.,2023

3. Association of measurable residual disease with survival outcomes in patients with acute myeloid leukemia;J.Short;JAMA Oncol.,2020

4. Minimal residual disease and stem cell transplantation outcomes;Cloos;Hematology,2019

5. MRD evaluation of AML in clinical practice: are we there yet?;Freeman;Hematology,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP